CaMKII in the cardiovascular system: sensing redox states - PubMed (original) (raw)

Review

CaMKII in the cardiovascular system: sensing redox states

Jeffrey R Erickson et al. Physiol Rev. 2011 Jul.

Abstract

The multifunctional Ca(2+)- and calmodulin-dependent protein kinase II (CaMKII) is now recognized to play a central role in pathological events in the cardiovascular system. CaMKII has diverse downstream targets that promote vascular disease, heart failure, and arrhythmias, so improved understanding of CaMKII signaling has the potential to lead to new therapies for cardiovascular disease. CaMKII is a multimeric serine-threonine kinase that is initially activated by binding calcified calmodulin (Ca(2+)/CaM). Under conditions of sustained exposure to elevated Ca(2+)/CaM, CaMKII transitions into a Ca(2+)/CaM-autonomous enzyme by two distinct but parallel processes. Autophosphorylation of threonine-287 in the CaMKII regulatory domain "traps" CaMKII into an open configuration even after Ca(2+)/CaM unbinding. More recently, our group identified a pair of methionines (281/282) in the CaMKII regulatory domain that undergo a partially reversible oxidation which, like autophosphorylation, prevents CaMKII from inactivating after Ca(2+)/CaM unbinding. Here we review roles of CaMKII in cardiovascular disease with an eye to understanding how CaMKII may act as a transduction signal to connect pro-oxidant conditions into specific downstream pathological effects that are relevant to rare and common forms of cardiovascular disease.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Oxidation and autophosphorylation both convert CaMKII into a Ca2+/CaM-independent enzyme by modification of defined CaMKII regulatory domain amino acids.

Figure 2

Figure 2

ROS and CaMKII both increase the slowly inactivating component of INa and enhance ICa facilitation, leading to action potential duration (APD) prolongation and early (EADs) and delayed (DADs) afterdepolarizations.

Figure 3

Figure 3

Reactive oxygen species and CaMKII in cardiomyocytes.

Figure 4

Figure 4

CaMKII is a likely participant in complex intercellular crosstalk between calcium and ROS signaling mechanisms.

Figure 5

Figure 5

The oxidation state of CaMKII is acutely sensitive to balance between ROS producing and ROS ablating processes

Figure 6

Figure 6

Mechanical and biological factors increase the production of ROS and activate CaMKII in vascular smooth muscle cells, resulting in impaired vessel tone, enhanced inflammatory response, and increased SMC migration, proliferation, and apoptosis.

Similar articles

Cited by

References

    1. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455. - PubMed
    1. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–1035. - PubMed
    1. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23–33. - PubMed
    1. Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S, Denney T, Jr., Powell P, McGiffin DC, Dell’Italia LJ. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60% J Am Coll Cardiol. 2010;55:671–679. - PMC - PubMed
    1. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005;97:1314–1322. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources